Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Seizures 2Brain Neoplasms 2beta-Thalassemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Seizures After Brain Tumor Surgery 1Neurofibromatosis 1 1Neoplasm, Residual 1Necrosis 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Influenza, Human 1Hematologic Neoplasms 1Glioma 1Chromosome Aberrations 1Chromosome 7, monosomy 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 8fludarabine phosphate 7fludarabine 5Busulfan 5Mycophenolic Acid 4Melphalan 4Whole-Body Irradiation 3Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Azacitidine 3venetoclax 2thymoglobulin 2Tacrolimus 2Rituximab 2Injections 2Hematopoietic Stem Cell Transplantation 2Granulocyte Colony-Stimulating Factor 2Cytarabine 2Cyclosporins 2Clofarabine 2Bone Marrow Transplantation 2Antilymphocyte Serum 2sulforaphane 1ruxolitinib 1pegylated granulocyte colony-stimulating factor 1monalizumab 1ivosidenib 1enasidenib 1cedazuridine 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anemia, Refractory, with Excess of Blasts × Levetiracetam × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡